Changes in Central Corneal Thickness over Time. The Ocular Hypertension Treatment Study

Ophthalmology

Volumn 115, Issue 9, 2008, Pages

  Brandt, James D ^a   Gordon, Mae O ^b   Beiser, Julia A ^b   Lin, Shan C ^c   Alexander, Monica Y ^d   Kass, Michael A ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PROSTAGLANDIN DERIVATIVE;

ARTICLE; CONTROLLED STUDY; CORNEA THICKNESS; EYE SURGERY; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TREATMENT DURATION;

EID: 50249116726     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2008.02.001     Document Type: Article

References (26)

1. Gordon M.O., Kass M.A., and Ocular Hypertension Treatment Study Group. The Ocular Hypertension Treatment Study: design and baseline description of the participants. Arch Ophthalmol 117 (1999) 573-583
2. Gordon M.O., Beiser J.A., Brandt J.D., et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 120 (2002) 714-720
3. Brandt J.D., Beiser J.A., Kass M.A., et al. Central corneal thickness in the Ocular Hypertension Treatment Study (OHTS). Ophthalmology 108 (2001) 1779-1788
4. Kass M.A., Heuer D.K., Higginbotham E.J., et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 120 (2002) 701-713
5. von Bahr G. Measurements of the thickness of the cornea. Acta Ophthalmol (Copenh) 26 (1948) 247-266
6. Martola E.L., and Baum J.L. Central and peripheral corneal thickness: a clinical study. Arch Ophthalmol 79 (1968) 28-30
7. Hansen F.K. A clinical study of the normal human central corneal thickness. Acta Ophthalmol (Copenh) 49 (1971) 82-89
8. Wolfs R.C., Klaver C.C., Vingerling J.R., et al. Distribution of central corneal thickness and its association with intraocular pressure: the Rotterdam Study. Am J Ophthalmol 123 (1997) 767-772
9. Foster P.J., Baasanhu J., Alsbirk P.H., et al. Central corneal thickness and intraocular pressure in a Mongolian population. Ophthalmology 105 (1998) 969-973
10. Wong T.Y., Foster P.J., Ng T.P., et al. Variations in ocular biometry in an adult Chinese population in Singapore: the Tanjong Pagar Survey. Invest Ophthalmol Vis Sci 42 (2001) 73-80
11. Eysteinsson T., Jonasson F., Sasaki H., et al. Central corneal thickness, radius of the corneal curvature and intraocular pressure in normal subjects using non-contact techniques: Reykjavik Eye Study. Acta Ophthalmol Scand 80 (2002) 11-15
12. Hahn S., Azen S., Ying-Lai M., et al. Central corneal thickness in Latinos. Invest Ophthalmol Vis Sci 44 (2003) 1508-1512
13. Nemesure B., Wu S.Y., Hennis A., et al. Corneal thickness and intraocular pressure in the Barbados Eye Studies. Arch Ophthalmol 121 (2003) 240-244
14. Aghaian E., Choe J.E., Lin S., and Stamper R.L. Central corneal thickness of Caucasians, Chinese, Hispanics, Filipinos, African Americans, and Japanese in a glaucoma clinic. Ophthalmology 111 (2004) 2211-2219
15. Tajimi Study Group. Corneal thickness and relating factors in a population-based study in Japan: the Tajimi Study. Am J Ophthalmol 144 (2007) 152-154
16. Weizer J.S., Stinnett S.S., and Herndon L.W. Longitudinal changes in central corneal thickness and their relation to glaucoma status: an 8 year follow up study. Br J Ophthalmol 90 (2006) 732-736
17. Wickham L., Edmunds B., and Murdoch I.E. Central corneal thickness: will one measurement suffice?. Ophthalmology 112 (2005) 225-228
18. Ocular Hypertension Treatment Study Group, and European Glaucoma Prevention Study Group. Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension. Ophthalmology 114 (2007) 10-19
19. Kymes S.M., Kass M.A., Anderson D.R., et al. Management of ocular hypertension: a cost-effectiveness approach from the Ocular Hypertension Treatment Study. Am J Ophthalmol 141 (2006) 997-1008
20. Dayanir V., Sakarya R., Ozcura F., et al. Effect of corneal drying on central corneal thickness. J Glaucoma 13 (2004) 6-8
21. McCarty C.A., Bansal A.K., Livingston P.M., et al. The epidemiology of dry eye in Melbourne, Australia. Ophthalmology 105 (1998) 1114-1119
22. Chia E.M., Mitchell P., Rochtchina E., et al. Prevalence and associations of dry eye syndrome in an older population: the Blue Mountains Eye Study. Clin Experiment Ophthalmol 31 (2003) 229-232
23. European Glaucoma Prevention Study Group. Central corneal thickness in the European Glaucoma Prevention Study. Ophthalmology 114 (2007) 454-459
24. Viestenz A., Martus P., Schlotzer-Schrehardt U., et al. Impact of prostaglandin-F(2alpha)-analogues and carbonic anhydrase inhibitors on central corneal thickness-a cross-sectional study on 403 eyes. [in German]. Klin Monatsbl Augenheilkd 221 (2004) 753-756
25. Harasymowycz P.J., Papamatheakis D.G., Ennis M., et al. Relationship between travoprost and central corneal thickness in ocular hypertension and open-angle glaucoma. Cornea 26 (2007) 34-41
26. Brandt J.D., Beiser J.A., Gordon M.O., et al. Central corneal thickness and measured IOP response to topical ocular hypotensive medication in the Ocular Hypertension Treatment Study. Am J Ophthalmol 138 (2004) 717-722